Polymer Capital Management (Us) LLC Arvinas, Inc. Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 16,842 shares of ARVN stock, worth $105,430. This represents 0.03% of its overall portfolio holdings.
Number of Shares
16,842Holding current value
$105,430% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
61.8MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$52.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$39.2 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$24.3 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$23.9 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$20.9 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $333M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...